OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

AES CORP. DL-,01/  US00130H1059  /

Frankfurt
2024-05-22  8:02:59 AM Chg. -0.1880 Volume Bid9:59:52 PM Ask9:59:52 PM Market Capitalization Dividend Y. P/E Ratio
19.2980EUR -0.96% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 13.74 bill.EUR - -
GlobeNewswire 05-21 Neon Bloom Finalizes Terms to Acquire Advanced Executive Sales, LLC
GlobeNewswire 05-21 Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients w...
GlobeNewswire 05-21 InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Poten...
GlobeNewswire 05-21 ChainBitVortex Unveils Robust Security Features in New Cryptocurrency Exchange
GlobeNewswire 05-20 Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
GlobeNewswire 05-20 Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ...
GlobeNewswire 05-16 Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lat...
GlobeNewswire 05-15 Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire 05-15 Andes, HiRain, and HPMicro Join Hands to Build RISC-V AUTOSAR Software Ecosystem
GlobeNewswire 05-15 UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT...
GlobeNewswire 05-13 SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Tre...
GlobeNewswire 05-13 Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
GlobeNewswire 05-09 PRP Group Launches Anonymous Edvisors Platform to Facilitate Feedback Sessions Between Administrator...
GlobeNewswire 05-08 Splashtop Earns 2024 Top Rated Awards by TrustRadius
GlobeNewswire 05-07 Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
GlobeNewswire 05-07 Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
GlobeNewswire 05-06 Inmagene Reports Positive Interim Results from Phase 2a Trial of IMG-007, a Nondepleting Anti-OX40 M...
GlobeNewswire 05-06 Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular isch...
GlobeNewswire 05-01 Realtors®’ Charitable Giving and Volunteering Increased Last Year
GlobeNewswire 04-30 Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, M...
GlobeNewswire 04-30 Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the ...
GlobeNewswire 04-29 Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s...
GlobeNewswire 04-29 Buildings across the nation to light up green for Mental Health Month in May
GlobeNewswire 04-26 MAX Power Makes High-Grade Lithium Discovery at Arizona’s Willcox Playa
GlobeNewswire 04-18 Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk...